Rhopalurus Princeps Venom Liquid
NDC Package 83555-100-05

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is an UNFINISHED DRUG part of the official NDC directory. Unfinished drugs include products like active ingredients some of which are used in bulk for further processing or compounding. The FDA requires a list of these drugs manufactured in a U.S. commercial distribution facility.

Rhopalurus Princeps Venom liquids is a drug for further processing. This formulation utilizes a liquid delivery system. Marketed by Phoenix Pharma Srl, this product is identified by NDC 83555-100.

Identification & Billing

NDC Package Code
83555-100-05
Package Description
50 mL in 1 BOTTLE, PLASTIC
Product Code
83555-100
11-Digit Billing Format
83555010005

Clinical Specifications

Proprietary Name
Rhopalurus Princeps Venom
Non-Proprietary Name
Rhopalurus Princeps Venom
Substance Name
Rhopalurus Princeps Venom
Dosage Form
Liquid - A dosage form consisting of a pure chemical in its liquid1 state. This dosage form term should not be applied to solutions.
Active Ingredient(s)
RHOPALURUS PRINCEPS VENOM 1 [hp_X]/mL

Regulatory & Marketing

Labeler Name
Phoenix Pharma Srl
Product Type
Drug For Further Processing
Marketing Category
DRUG FOR FURTHER PROCESSING - A drug (other than the bulk ingredient API) that is in an interim stage of manufacture, processing, preparation, or packaging, and not ready for human or animal use.
Start Marketing Date
08-27-2023
Listing Expiration
12-31-2026
Exclude Flag
N
Unfinished Product
Yes
Sample Package
N/A

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 83555-100-05 identifies a specific commercial package of 50 ml in 1 bottle, plastic of Rhopalurus Princeps Venom (UNFINISHED drug), drug for further processing labeled by Phoenix Pharma Srl. This liquid is formulated for use and contains rhopalurus princeps venom as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Phoenix Pharma Srl on August 27, 2023. The current certification is valid through December 31, 2026.

How is this Phoenix Pharma Srl product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 83555010005. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
83555-100-05
11-Digit CMS (5-4-2)
83555-0100-05

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.